ライフサイエンスコーパス: messenger RNA

1 ltering exon 5 inclusion in SmgGDS pre-mRNA (messenger RNA).

2 h rapid upregulation of thrombopoietin (TPO) messenger RNA.

3 ide, and dimethyloxalylglycine, raised NCOA4 messenger RNA.

4 -surface levels of PVR but not levels of Pvr messenger RNA.

5 ch binds to and prevents translation of TP53 messenger RNA.

6 esponding cis-regulatory elements in the pre-messenger RNA.

7 t cell density and levels of NOTCH3 and JAG2 messenger RNA.

8 t on how ribosomes can ignore stop codons in messenger RNA.

9 elets, suggesting dynamic trafficking of the messenger RNA.

10 uncleaved by ribonucleases and assemble onto messenger RNA.

11 orchestrate maturation and stabilisation of messenger RNA.

12 function for TET-mediated m(5)C oxidation in messenger RNA.

13 within the 3'-untranslated regions of PFKFB3 messenger RNA.

14 ated by binding of CPEB4 to its untranslated messenger RNA.

15 iptionally regulate the expression levels of messenger RNAs.

16 NA binding compared with cytoplasm-localized messenger RNAs.

17 lly drives expression of its own independent messenger RNAs.

18 rom short regulatory transcripts to gigantic messenger RNAs.

19 machinery, preventing the synthesis of viral messenger RNAs.

20 mostly intron retention, in several hundred messenger RNAs.

21 nces within 3'-untranslated regions of those messenger RNAs.

22 h Argonaute (AGO) proteins to repress target messenger RNAs.

23 PAIR-MaP to human RNase MRP and 2 bacterial messenger RNA 5' untranslated regions reveals functional

24 ed blood and urine samples, as well as CXCL9 messenger RNA (a marker of graft rejection) at elevated

25 Delivered as messenger RNA, ABE8s induce no significant levels of sin

26 ukin 6 and interleukin 1 receptor antagonist messenger RNA, alterations in synaptic strength, and nor

27 egulatory elements found mostly in bacterial messenger RNA and are classified into subtypes based on

28 omplex pseudouridine landscape that includes messenger RNA and diverse classes of noncoding RNA in hu

29 small-interfering RNA and then measuring F7 messenger RNA and FVII protein expression.

30 is and immunohistochemistry (IHC) to examine messenger RNA and protein changes in glands over time.

31 with sensitive sAML blasts, displayed higher messenger RNA and protein expression of TCF7L2, JMJD6, a

32 Without the E'-box, Per2 messenger RNA and protein expression remain at mid-to-hi

33 d sites, which was associated with increased messenger RNA and protein expression.

34 Sox9 messenger RNA and protein levels are both upregulated in

35 revealed significant up-regulation of CXADR messenger RNA and protein levels in plaque-invested caro

36 ared with AA MPs, SS MPs increased EC ICAM-1 messenger RNA and protein levels, as well as neutrophil

37 pared with normal B and T lymphocytes at the messenger RNA and protein levels.

38 have an almost complete loss of PTPRJ at the messenger RNA and protein levels.

39 This was confirmed at the messenger RNA and protein levels.

40 ues from patients had higher levels of PVRL1 messenger RNA and protein than nontumorous tissues.

41 ative gene in Huntington's disease, reducing messenger RNA and protein throughout the brain.

42 Levels of CDH11 messenger RNA and protein were significantly higher in C

43 enzyme-linked immunosorbent assay, and COX2 messenger RNA and protein, compared with control biopsie

44 (m6A) has recently been found abundantly on messenger RNA and shown to regulate most steps of mRNA m

45 ense oligonucleotide designed to inhibit HTT messenger RNA and thereby reduce concentrations of mutan

46 MECP2 deletion altered expression of 284 messenger RNAs and 244 long noncoding RNAs, including th

47 ng nuclear maturation of most eukaryotic pre-messenger RNAs and long non-coding RNAs, introns are rem

48 ted in culture and used in array analyses of messenger RNAs and long noncoding RNAs.

49 tinct higher-order architectures between pre-messenger RNAs and mRNAs.

50 get genes, followed by reduced expression of messenger RNAs and proteins regulated by the Wnt pathway

51 post-transcriptional regulators that target messenger RNAs and repress their translation into protei

52 nown for their role in reading the codons on messenger RNAs and translating them into proteins.

53 t polypeptides that are encoded by defective messenger RNAs and undergo stalling at the ribosome duri

54 d by quantitative polymerase chain reaction (messenger RNA) and enzyme-linked immunosorbent assay (pr

55 cules, some encoding proteins (the so-called messenger RNAs) and others lacking protein-coding potent

56 s, nitrite production, autophagy, signaling, messenger RNA, and cytokine levels.

57 zymes, determination of the cap structure of messenger RNA, and development of poxviruses as gene exp

58 and SYF2 were found associated with ECT2 pre-messenger RNA, and ECT2-Ex5+ isoform depletion reduced d

59 ed evidence for abasic sites in nascent RNA, messenger RNA, and ribosomal RNA from yeast and human ce

60 d the degradation of several host interferon messenger RNAs, and thus acted as a negative feedback re

61 Chemical modifications to messenger RNA are increasingly recognized as a critical

62 Faulty or damaged messenger RNAs are detected by the cell when translating

63 These chimeric messenger RNAs are present in normal human cells, and ar

64 whereas markers of protein degradation, murf messenger RNAs, are higher at night.

65 CRISPR-Cas gene editing and messenger RNA-based protein replacement therapy hold tre

66 le epigenetic modification found not only in messenger RNAs but also in non-coding RNAs, m(6)A affect

67 dant in untranslated regions (UTRs) of human messenger RNAs, but their functional importance remains

68 Targeting Tmprss6 messenger RNA by Tmprss6-ASO was proven to be effective

69 is unclear how newly synthesized genomes and messenger RNAs can travel from these sealed replication

70 tudies indicate that Rpt1- and Rpt2-encoding messenger RNAs co-localize in these particles that conta

71 patients with IBD had reduced levels of CRT messenger RNA compared with those from control individua

72 similar changes in the abundance of specific messenger RNAs, consistent with their ability to produce

73 We identify messenger RNA-decapping enzyme 1A (DCP1A) as a key regul

74 The apolipoprotein B messenger RNA editing enzyme, catalytic polypeptide-like

75 The messenger RNA encodes the prostaglandin PGD(2) synthesiz

76 Gene expression analysis reveals that messenger RNAs encoding genes involved in metabolic, vas

77 eated celiac disease had increased levels of messenger RNAs encoding IL15 receptor subunit alpha (IL1

78 Levels of messenger RNAs encoding inflammatory cytokines were unch

79 th pachytene piRNA precursor transcripts and messenger RNAs encoding piRNA biogenesis factors.

80 6 piRNAs repress gene expression by cleaving messenger RNAs encoding proteins required for sperm func

81 id cells and cells expressing Cxcr2 and Lgr5 messenger RNAs (epithelial progenitors) compared with mi

82 gonad-specific variant of the heterodimeric messenger RNA export receptor Nxf1-Nxt1 and the Piwi-ass

83 Cytokine messenger RNA expressed in cell pellets and proteins sec

84 promoter, which is required for Bdnf exon IV messenger RNA expression and for the extinction of condi

85 An analysis of messenger RNA expression clusters compared with miRNA ex

86 Our Western blotting and messenger RNA expression data demonstrated that canaglif

87 ion (qPCR) were employed to assess Ddr1/DDR1 messenger RNA expression in mouse and human tissues.

88 also report that circulating SQSTM1 and the messenger RNA expression levels of SQSTM1 and INSR in pe

89 We collected data on DNA sequences, messenger RNA expression levels, and patient survival ti

90 Messenger RNA expression of interleukin-6 and the costim

91 Altered metabolite levels and messenger RNA expression of metabolic enzymes suggest th

92 are independent of changes in cognate linear messenger RNA expression or estimated brain cell-type pr

93 Immunohistochemistry, global messenger RNA expression, and cell-signaling pathway ana

94 er permeability, with altered tight-junction messenger RNA expression, increased brain levels of infl

95 Messenger RNA extraction from the same paraffin-embedded

96 CCR5 3' untranslated region, protecting CCR5 messenger RNA from Raly-mediated degradation.

97 otes, RNA polymerase II (RNApII) transcribes messenger RNA from template DNA.

98 In addition, RD2 influences the abundance of messenger RNAs from >100 core chromosomal GAS genes.

99 nontemplated nucleotide addition to protect messenger RNAs from deadenylation.

100 Selections of messenger RNAs from mRNA libraries using translation ext

101 was assessed for its ability to semiquantify messenger RNA immune-related markers directly from blood

102 r genome atlas for levels of KDM3A and DCLK1 messenger RNA in human pancreatic ductal adenocarcinoma

103 We compared levels of CDH11 messenger RNA in human pancreatitis and pancreatic cance

104 ales had more OT-immunoreactive cells and OT messenger RNA in the paraventricular nucleus of the hypo

105 cing the upregulation of IL23R, CCR6 and KIT messenger RNA in these cells.

106 Neurons also maintain a subset of messenger RNAs in a translationally silent state, which

107 t IFIT2 binds directly to viral and cellular messenger RNAs in AU-rich regions, with bound cellular t

108 ured goblet cell density and levels of Notch messenger RNAs in BE tissues from 164 patients, with and

109 eins, to map spliceosome engagement with pre-messenger RNAs in human cell lines.

110 We compared levels of messenger RNAs in pancreatic tumors and normal pancreas

111 fication of the levels of proteins and their messenger RNAs in single cells suggests that translation

112 terspersed element RNAs, noncoding RNAs, and messenger RNAs in trans Some L1-mediated retrotransposit

113 d posttranscriptional regulation of AR mRNA (messenger RNA) in CRPC.

114 P), which translationally represses specific messenger RNAs, including the PI3K catalytic isoform p11

115 This NCOA4 messenger RNA induction occurred within 3 hours, precede

116 ng exogenous nucleic acids, especially large messenger RNAs, into cell-secreted exosomes leads to low

117 sensitizes neurons to glutamate by targeting messenger RNAs involved in glutamate receptor signalling

118 In silico analysis revealed that messenger RNAs involved in glutamate receptor signalling

119 The 3' poly(A) tail of messenger RNA is fundamental to regulating eukaryotic ge

120 ulating the expression of immune suppressive messenger RNAs is most well-documented.

121 bined single-cell combinatorial indexing and messenger RNA labeling (sci-fate), which uses combinator

122 gnals, calculated from the trajectory of ZEB messenger RNA level.

123 a low ratio also had higher NAIP and PYCARD messenger RNA levels after lipopolysaccharide stimulatio

124 tipsychotic-exposed monkeys, we found higher messenger RNA levels for 1) most NF-kappaB family member

125 0% of the genes with significantly decreased messenger RNA levels in the mutant mouse cortex are invo

126 ls rapidly absorbed labeled fatty acids, and messenger RNA levels of Lgr5(+) stem cell markers (Lgr5,

127 imilar pattern of elevated NF-kappaB-related messenger RNA levels was seen in adult mice that receive

128 AC6 messenger RNA levels were the highest of all 9 membrane-

129 thin 20 min after stimulation, prior to peak messenger RNA levels.

130 ly parallel reporter assays from a synthetic messenger RNA library composed of over one million 5' UT

131 n that influences nearly every aspect of the messenger RNA lifecycle.

132 We identify two distinct pathways of messenger RNA localization to mitochondria, each associa

133 ed QTL and correlated the abundance of cecal messenger RNA, luminal microflora, physiology, and behav

134 icroRNA can target many functionally related messenger RNAs making microRNAs powerful epigenetic regu

135 ome-wide mapping in ESCs reveals hundreds of messenger RNAs marked by 5hmC at sites characterized by

136 cation, contributing to different aspects of messenger RNA metabolism(5,6), is detectable on the majo

137 -separated droplets that organize and manage messenger RNA metabolism, cell signaling, biopolymer ass

138 N(6)-methyladenosine (m(6)A) messenger RNA methylation has emerged as an important mo

139 ddress the regulation and functional role of messenger RNAs, microRNAs, long noncoding RNAs, and circ

140 nd 0.880 under the full transcript or mature messenger RNA models, respectively) compared to the stat

141 sine (m(6)A) is the most widespread internal messenger RNA modification in humans.

142 n within the PEST-encoding region of the LLO messenger RNA (mRNA) (hly).

143 productively rearranged Igh allele, the Igh messenger RNA (mRNA) (IgHR) from a nonproductively rearr

144 ssing a codon optimized Rs-rbcLS operon, the messenger RNA (mRNA) abundance was ~25% of rbcL transcri

145 neous activation due to a global increase in messenger RNA (mRNA) abundance, which reduces the thresh

146 EGFP messenger RNA (mRNA) and GFP plasmid DNA (pDNA) were use

147 are extensively characterized, extracellular messenger RNA (mRNA) and long non-coding RNA (lncRNA) st

148 Circulating messenger RNA (mRNA) and microRNA (miRNA) were sequenced

149 ecludes tractable analytical expressions for messenger RNA (mRNA) and protein distributions.

150 wild-type BRAF were shown to increase PD-L1 messenger RNA (mRNA) and protein expression that was att

151 ishes a latent infection, with low levels of messenger RNA (mRNA) and protein expression, evolved to

152 MIR200C-3p and decreased levels of occludin messenger RNA (mRNA) and protein.

153 olymerase chain reaction (PCR) for detecting messenger RNA (mRNA) and quantitative PCR for HBoV1 geno

154 Even though liver Hamp messenger RNA (mRNA) and serum hepcidin levels do not di

155 The posttranscriptional modification of messenger RNA (mRNA) and transfer RNA (tRNA) provides an

156 e is that ribosomes read the genetic code in messenger RNA (mRNA) as triplets of nucleotides in a sin

157 paced microRNA (miRNA) target sites within a messenger RNA (mRNA) can act cooperatively, leading to m

158 The 5' messenger RNA (mRNA) cap structure enhances translation

159 C7 extension of sarecycline extends into the messenger RNA (mRNA) channel to form a direct interactio

160 Recent advances in messenger RNA (mRNA) codon optimization, synthesis, and

161 Control of messenger RNA (mRNA) decay rate is intimately connected

162 e termination of translation, which triggers messenger RNA (mRNA) decay.

163 tion is autoregulated by feedback control of messenger RNA (mRNA) degradation via an unknown mechanis

164 nally repressed by RISCs without substantial messenger RNA (mRNA) destabilization.

165 port preclinical studies evaluating systemic messenger RNA (mRNA) encoding human alpha-Gal A in wild-

166 The messenger RNA (mRNA) encoding the guanine nucleotide exc

167 Injection of messenger RNA (mRNA) encoding the PC1-CTT into pkd1-morp

168 ffects of GC exposure during neurogenesis on messenger RNA (mRNA) expression and DNA methylation (DNA

169 luated morphometric, immunohistochemical and messenger RNA (mRNA) expression changes in coeliac disea

170 ic region of chromosome 2p with no impact in messenger RNA (mRNA) expression was more common in RB (2

171 Deletion of the murine SE reduces Atoh7 messenger RNA (mRNA) fivefold but does not recapitulate

172 Messenger RNA (mRNA) has recently emerged as a promising

173 receptor-gamma coactivator-alpha (PPARGC1A) messenger RNA (mRNA) in skin fibroblast cultures from th

174 (6)A) regulates stability and translation of messenger RNA (mRNA) in various biological processes.

175 sense-mediated knockdown of endogenous ssbp1 messenger RNA (mRNA) in zebrafish resulted in compromise

176 CUG triplet located in the 5' leader of POLG messenger RNA (mRNA) initiates almost as efficiently (~6

177 vement of RNA polymerase (RNAP)-synthesizing messenger RNA (mRNA) is coordinated with the movement of

178 Ribosomal protein S6K (S6K) messenger RNA (mRNA) levels were increased and AMPKalpha

179 For example, messenger RNA (mRNA) localization by molecular motor-dri

180 Advances in the detection and mapping of messenger RNA (mRNA) N(6)-methyladenosine (m(6)A) and 5-

181 d in vivo enabled by bioreducible lipid/Cas9 messenger RNA (mRNA) nanoparticle is reported.

182 verting enzyme 2 (ACE2), was not detected by messenger RNA (mRNA) or protein in platelets.

183 N(6)-Methyladenosine (m(6)A) in messenger RNA (mRNA) regulates its stability, splicing,

184 Messenger RNA (mRNA) represents a promising next-generat

185 There is a growing appreciation that messenger RNA (mRNA) sequences responsible for directing

186 (m6A) can play important roles in regulating messenger RNA (mRNA) splicing, export, stability and tra

187 The nuclear envelope serves as important messenger RNA (mRNA) surveillance system.

188 Messenger RNA (mRNA) therapeutics has expanded the abili

189 itiation factor 4F (eIF4F)] at the 5' end of messenger RNA (mRNA) to form the 48S initiation complex

190 creased a fraction of these glucagon-induced messenger RNA (mRNA) transcript levels.

191 f the enzymatic functions required for viral messenger RNA (mRNA) transcription and replication: RNA

192 , such as between microRNAs (miRNAs) and the messenger RNA (mRNA) transcripts they regulate, and ther

193 inoacyl-tRNA determines the reading frame of messenger RNA (mRNA) translation by the ribosome.

194 how that BCL11A is regulated at the level of messenger RNA (mRNA) translation during human hematopoie

195 IN1, and mLST8, forming CTORC2, and controls messenger RNA (mRNA) translation through phosphorylation

196 Here, we evaluated lipid-encapsulated messenger RNA (mRNA) vaccines and a DNA plasmid vaccine

197 m children without liver disease (controls); messenger RNA (mRNA) was isolated, randomly assigned to

198 SCs that expressed increased levels of Atoh1 messenger RNA (mRNA), acquired a gene expression signatu

199 (HR) HPV DNA, HPV16/18 genotyping, HPV E6/E7 messenger RNA (mRNA), and p16/Ki-67 dual stain in a popu

200 givosiran had sustained reductions in ALAS1 messenger RNA (mRNA), delta aminolevulinic acid, and por

201 Regulation of enzymatic 5' decapping of messenger RNA (mRNA), which normally commits transcripts

202 oring interleukin-1beta (IL-1beta)-regulated messenger RNA (mRNA)-lncRNA pairs in ECs.

203 Translation depends on messenger RNA (mRNA)-specific initiation, elongation, an

204 ract, respectively, on levels of protein and messenger RNA (mRNA).

205 novo expression of proteins encoded by cargo messenger RNA (mRNA).

206 Cap)1G) or retained in cells as translatable messenger RNAs (mRNAs) ((Cap)2G and (Cap)3G).

207 roach to treat PA using a combination of two messenger RNAs (mRNAs) (dual mRNAs) encoding both human

208 l repertoire of erythroid miR-144/451 target messenger RNAs (mRNAs) and associated cellular pathways

209 taneously inhibits the translation of globin messenger RNAs (mRNAs) and selectively enhances the tran

210 ve been shown to suppress the translation of messenger RNAs (mRNAs) by directing the RNA-induced sile

211 g RNAs that modulate the translation-rate of messenger RNAs (mRNAs) by directing the RNA-induced sile

212 Some messenger RNAs (mRNAs) contain motifs that promote delib

213 onal gene regulation, and they interact with messenger RNAs (mRNAs) either by degradation or by trans

214 We analyzed levels of messenger RNAs (mRNAs) encoding proteins involved in aut

215 Recently, messenger RNAs (mRNAs) have emerged as a promising platf

216 e sense complementary RNAs (cRNAs) and viral messenger RNAs (mRNAs) inside infected host cells.

217 Nuclear export of messenger RNAs (mRNAs) is intimately coupled to their sy

218 Although eukaryotic messenger RNAs (mRNAs) normally possess a 5' end N(7)-me

219 nducted massively parallel screens targeting messenger RNAs (mRNAs) of a green fluorescent protein tr

220 We analyzed BE tissues for messenger RNAs (mRNAs) that associate with BE progressio

221 tory molecules that act by binding to target messenger RNAs (mRNAs) to reduce protein synthesis and h

222 binding to dozens of small RNAs (sRNAs) and messenger RNAs (mRNAs) to regulate mRNA-expression level

223 sed proteins are coupled with their encoding messenger RNAs (mRNAs) via a high-affinity stem-loop RNA

224 g IL-6 family cytokines, expression of these messenger RNAS (mRNAs) was assessed.

225 366 long noncoding RNAs (lncRNAs), and 3266 messenger RNAs (mRNAs) were differentially expressed (DE

226 a translation-incompetent complex for select messenger RNAs (mRNAs) with eIF4A.

227 Although messenger RNAs (mRNAs), and the proteins that they encod

228 LY proteins function together to export many messenger RNAs (mRNAs), but we found that ALY1 is unique

229 h noncoding RNAs (ncRNAs) and protein-coding messenger RNAs (mRNAs), degrading ncRNAs that fail to fo

230 cluding changing the translation of specific messenger RNAs (mRNAs), provide a rapid means to respond

231 iRNAs) regulate the levels of translation of messenger RNAs (mRNAs).

232 the delivery of the first aminoacyl-tRNA to messenger RNAs (mRNAs).

233 Translation of mitochondrial messenger RNA (mt-mRNA) is performed by distinct mitorib

234 leotide, thereby increasing the chances of a messenger RNA of being capped during mRNA maturation, wh

235 <= 0.001) and significant downregulation in messenger RNA of shared targets superoxide dismutase 2 (

236 , the BCR-ABL1 fusion gene and its companion messenger RNA offers a unique target differentiating can

237 st TRDs is the presence of toxicity from the messenger RNA or protein encoded by the gene harboring t

238 se in level of interleukin (IL) 1beta (IL1B) messenger RNA (P for comparison = .005), increased IL1B

239 2.69-fold increase in the expression of TNF messenger RNA (P for comparison = 0.013) compared with c

240 e spliceosome-catalyzed process by which pre-messenger RNA (pre-mRNA) is processed to mature mRNA, is

241 g factor U2AF65/Mud2p functions in precursor messenger RNA (pre-mRNA) processing.

242 The control of precursor-messenger RNA (pre-mRNA) splicing is emerging as an impo

243 nizes the 3'-splice site (3'SS) of precursor messenger RNA (pre-mRNA) through non-Watson-Crick pairin

244 es proper splicing of human alpha-globin pre-messenger RNA (pre-mRNA).

245 zoan replication-dependent histone precursor messenger RNAs (pre-mRNAs) contains the U7 small nuclear

246 The spliceosome removes introns from messenger RNA precursors (pre-mRNA).

247 nally, in situ hybridization showed that DMD messenger RNA primarily localizes in the nuclear compart

248 ngly imply a role for aberrant regulation of messenger RNA processing in MCL pathobiology.

249 ol essential biological functions, including messenger RNA processing, cell signalling and embryogene

250 (m(6)A) plays important roles in regulating messenger RNA processing.

251 ted and analyzed by histologic, metabolomic, messenger RNA quantification, and RNA-sequencing analyse

252 were measured for protein (Western blot) and messenger RNA (quantitative reverse transcriptase polyme

253 Pharmacological targeting of messenger RNA represents an emerging, innovative approac

254 tion, stability, or localization of maternal messenger RNAs required for patterning decisions before

255 am of terminators to block nuclear export of messenger RNAs resulting from RNA polymerase readthrough

256 e until they bind RNA aptamers inserted into messenger RNAs, resulting in fluorescent RNA-protein com

257 ethyltransferase identification (DamID) with messenger RNA sequencing of the same cell (scDam&T-seq).

258 Microglia maintained a unique messenger RNA signature 24 days after RSD.

259 -connectivity mapping data sets queried with messenger RNA signature of RUNX1 knockdown identified no

260 and upregulation of proteins associated with messenger RNA splicing via the spliceosome.

261 spliceosome with the ability to activate pre-messenger RNA splicing.

262 etes larger amounts of GGT, and a rifampicin messenger RNA stability study showed that one reason for

263 tein production rate, folding, activity, and messenger RNA stability.

264 isms used by viruses to manipulate miRNA and messenger RNA stability.

265 roles in the stress response(1,2), maternal messenger RNA storage(3), synaptic plasticity(4), tumour

266 plexes recognized by ADARs as readout of pre-messenger RNA structures, we reveal distinct higher-orde

267 in (Sur) biomarkers: the Sur protein and its messenger RNA (Sur mRNA), including immunosensors, elect

268 ndent platelet aggregation and tissue factor messenger RNA synthesis by monocytes.

269 was found to robustly activate the transfer-messenger RNA system, even when transcription was inhibi

270 MicroRNAs (miRNAs) base-pair to messenger RNA targets and guide Argonaute proteins to me

271 in Argonaute proteins to guide repression of messenger RNA targets.

272 ntified a 3' untranslated region in the TP53 messenger RNA that bound miR675-5p; binding resulted in

273 Isoforms of the Pax3 messenger RNA that differ in their 3' untranslated regio

274 rent motifs in the 3' untranslated region of messenger RNAs that were sex differentially translated.

275 main, canonical protein encoded on the same messenger RNA, thereby revealing the use of functional b

276 During trans-translation, transfer-messenger RNA (tmRNA) and small protein B (SmpB) togethe

277 cation of reference genes 16S rRNA, transfer-messenger RNA (tmRNA), pre-16S rRNA, and rpoB by reverse

278 degradation of superoxide dismutase 1 (SOD1) messenger RNA to reduce SOD1 protein synthesis.

279 associated with a relative deficiency of GLS messenger RNA transcribed from the expanded allele, whic

280 ) that cooperate to maintain muscle-specific messenger RNA transcription.

281 cts the efficiency with which individual pre-messenger RNA transcripts are productively processed acr

282 pathogenesis of PH via the direct binding to messenger RNA transcripts for degradation or inhibition

283 nsposon Gag genes and mediates intercellular messenger RNA transfer.

284 A common assumption in studies of local messenger RNA translation is that the anti-puromycin sta

285 hich could then result in increasing the GSN messenger RNA translation via reduced miR binding to its

286 clear factor kappaB, and reduces oncoprotein messenger RNA translation, is a potential novel treatmen

287 icroRNA-377 precursor, which represses Vegfa messenger RNA translation, is druggable in a selective m

288 in RNA in situ hybridization to detect HHV-6 messenger RNA (U41 and U57 transcripts) in lung tissue.

289 e a foundation from which to optimize future messenger RNA vaccination studies against NiV and other

290 of a lipid nanoparticle nucleoside-modified messenger RNA vaccine encoding the soluble Hendra virus

291 dynamics to draining lymph nodes of a model messenger RNA vaccine labelled with the probe.

292 se 1, dose-escalation, open-label trial of a messenger RNA vaccine, mRNA-1273, which encodes the stab

293 Therapeutic messenger RNA vaccines enable delivery of whole antigens

294 Levels of KDM3A and DCLK1 messenger RNA were higher in human PDAC than nontumor pa

295 ed HIV DNA, unspliced HIV RNA, and chemokine messenger RNA were quantified by quantitative polymerase

296 Levels of NLRC5 messenger RNA were significantly increased in gastric ti

297 e whole DRG transcriptome and 66 genes whose messenger RNAs were sex differentially actively translat

298 L-3'-UTRs containing BDNF messenger RNAs, which migrate to distal dendrites of pyr

299 receptor (IR) have a 50% reduction in Arrdc3 messenger RNA, while, conversely, mice with liver-specif

300 Messenger RNAs whose translation is highly active in qui